Skip to main content
. Author manuscript; available in PMC: 2021 Jan 13.
Published in final edited form as: Lung Cancer. 2016 Sep 28;101:104–110. doi: 10.1016/j.lungcan.2016.09.015

Table 5.

Univariate and multiple proportional hazards regression analyses for patients with thymic carcinoma (n=34)

Univariate Multiple Regression
Variable Comparison* (N) P (Log-rank) P (Trend) Hazard Ratio (HR) 95% CI Hazard Ratio (HR) 95% CI
Age 0.17 0.31
<40 (6) vs. 40–51 (6) 0.15 0.02, 1.29
<40 vs. 51–62 (9) 0.29 0.07, 1.13
<40 vs. >62 (13) 0.39 0.11, 1.38
Sex Female (13) vs. Male (21) 0.32 1.72 0.59, 5.04 2.32 0.74, 7.22
Race
Other (8) vs. White (26) 0.83 1.15 0.32, 4.09
Stage IIB/III (4), IVA (4), IVB (26) 0.87 0.62
IIB/III/IVA (8) vs. IVB (26) 0.59 1.40 0.39, 4.99 1.93 0.51, 7.38
Mesothelin expression >50 (19) vs. <50 (15) 0.003 4.46 1.55, 12.80 5.39 1.77, 16.40
*

The reference group used to calculate the hazard ratio is indicated first.